Intellia Therapeutics Inc buy Canaccord Genuity Group Inc.
Start price
03.03.26
/
50%
€11.99
Target price
03.03.27
€41.04
Performance (%)
-2.29%
Price
03.03.26
€11.71
Summary
This prediction is currently active. With a performance of -2.29%, the BUY prediction by Canaccord_Genuity_Gr is trending in the wrong direction. This prediction currently runs until 03.03.27. The prediction end date can be changed by Canaccord_Genuity_Gr at any time. Canaccord_Genuity_Gr has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Intellia Therapeutics Inc | -2.29% |
| iShares Core DAX® | -1.306% |
| iShares Nasdaq 100 | 1.979% |
| iShares Nikkei 225® | 0.593% |
| iShares S&P 500 | 1.425% |
Comments by Canaccord_Genuity_Gr for this prediction
In the thread Intellia Therapeutics Inc diskutieren
Intellia Therapeutics (NTLA) had its price target lowered by Canaccord Genuity Group Inc. from $54.00 to $48.00. They now have a "buy" rating on the stock.
Ratings data for NTLA provided by MarketBeat
Stopped prediction by Canaccord_Genuity_Gr for Intellia Therapeutics Inc
Intellia Therapeutics Inc
Start price
Target price
Perf. (%)
€33.50
13.04.23
13.04.23
€59.72
13.04.24
13.04.24
-29.85%
14.04.24
14.04.24
